Quality Determinants of Organized Breast Cancer Screening Programs

Introduction

Methodology

Achieving Quality through a Client Service Approach

• Client Service Approach
• Role of Receptionists/Scheduling Personnel
• Role of Mammography Technologists and Clinical Examiners
• Minimizing Anxiety
• Education and Counselling
• References

Recruitment and Capacity

• Enrollment Objectives
• Capacity
• Promotion - Strategies to Recruit Women
• Promotion - Family Physicians and Screening
• Community Promotion
• References

Retention

• Return Visits to Mammography Screening Programs
• Factors Associated with Reattendance and/or Compliance
• Recall
• References

Quality of Mammography

• Education and Training
• Quality Control
• References

Reporting

• Screening Report
• Pathology Report
• References

Communicating Results

• Communicating Results to the Physician
• Communicating Results to the Woman
• References

Follow-up and Diagnostic Workup

• References

Program Evaluation

• References

Special Projects

• Quality Assurance Survey
• Pan-Canadian Study
• References

Appendix: Breast Cancer Guidelines for the Pathological Examination and Reporting of Breast Specimens

 

Our mission is to help the people of Canada maintain and improve their health.
Health Canada

Ce document est aussi offert en français sous le titre : Déterminants de la qualité des programmes organisés de dépistage du cancer du sein

© Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and Government Services Canada, 2003
Cat. No. H39-407/2003E
ISBN 0-662-33984-3

Quality Determinants Working Group

Dr. Fred Alexander (AB)
Tom Baker Cancer Centre
Department of Pathology
1331- 29 St. NW
Calgary, (AB) T2N 4N2
Tel: (403) 944-1720
Fax:(403) 270-8952

Dr. Diane Major (QC), CHAIR
Coordonnateur de recherche
Institut national de santé publique du Québec
Direction Systèmes de soins et services
Centre d'expertise en dépistage
945 Wolfe, 5e étage
Ste-Foy, (QC) G1V 5B3
Tel: (418) 650-5115 poste 5525
Fax: (418) 527-8760

Dr. Penny Barnes (NS)
Division of Anatomical Pathology
7th Fl. DJ MacKenzie Bldg.
QEII Health Sciences Ctr.
5788 University Ave.
Halifax, NS B3H 1V8
Tel: Work (902) 473-2832

Dr. Nancy Wadden (NF)
Diagnostic Imaging
St-Clare's Mercy Hospital
154 Lemarchant Road
St-John's, Newfoundland A1C 5B8
Tel: (709) 777-5657
Fax: (709) 777-5793

Gregory Doyle (NF)
Breast Screening Program for
Newfoundland and Labrador
38 Ropewalk Lane
St. John's, NF A1E 5T2
Tel: (709) 777-5064
Fax: (709) 777-5069

Dana Dudar (AB)
Screen tests
1040 7th Ave South West, suite 120
Calgary, (AB) T2P 3G9
Tel: (403) 262-4470
Fax: (403) 290-0933

Katie Watters (MB)
Education Coordinator
Manitoba Breast Screening Program
5-25 Sherbrook Street
Winnipeg, MB R3C 2B1
Tel: (204) 788-8630
Fax: (204) 788-1594

Health Canada

Christina Bancej, Manager
Screening and Early Detection Section
Chronic Disease Prevention, CCDPC
PHAC, Health Canada
Jeanne Mance Building
Tunney's Pasture
P.L. 1915D1, Room 1591
Ottawa, ON K1A 1B4
Tel: (613) 952-6143
Fax: (613) 954-8631

Jay Onysko
Screening and Early Detection Section
Chronic Disease Prevention, CCDPC
PHAC, Health Canada
PL 0602E2, Room 2426, Building #6
Tunney's Pasture,
Ottawa, ON K1A 0L2
Tel: (613) 957-3554
Fax: (613) 941-5497

Heide Ebenhoeh
Senior Program Manager
Screening and Early Detection Section
Chronic Disease Prevention, CCDPC
PHAC, Health Canada
Jeanne Mance Building
Tunney's Pasture
P.L. 1910C, Room 1057C
Ottawa, ON K1A 1B4
Tel: (613) 954-6276
Fax: (613) 941-2633

Asako Gomi
Surveillance Coordinator
2nd Floor, Room 2424, LCDC Building
Tunney's Pasture
Ottawa, ON K1A0L2
Tel: (613) 952-6163
Fax: (613) 941-5497

Louise Rochette (QC)
Consultant to Working Group
484, Régaud
Beauport, QC G1C 6B3
Tel: (418) 666-7000 ext. 378
Fax: (418) 666-2776

Acknowledgements

The Quality Determinants document was developed by Dr. Diane Major and Ms. Louise Rochette, of Institut national de santé publique du Québec in consultation with the Canadian Breast Cancer Screening Initiative's (CBCSI) Quality Determinants Working Group. This document was approved by the National Committee of the CBCSI, November 2002. We also wish to acknowledge Ms. Marion Harrison, Screen Programs CancerCare Manitoba, Winnipeg, MB, for providing feedback on this document, and the Scientific Publication and Multimedia Services of the Public Health Agency of Canada, Health Canada, for editing, coordinating the translation and preparing the document for publication.